Chimeric antigen receptors in the brain: Can we tackle glioblastoma with engineered NK cells?

被引：0
|
作者：
Roth, Patrick [1 ,2 ,3 ]
机构：
[1] Univ Hosp Zurich, Frauenklinikstr 26, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Dept Neurol, Frauenklinikstr 26, CH-8091 Zurich, Switzerland
[3] Brain Tumor Ctr, Frauenklinikstr 26, CH-8091 Zurich, Switzerland
来源：
NEURO-ONCOLOGY | 2023年 / 25卷 / 11期
关键词：
D O I：
10.1093/neuonc/noad131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2072 / 2073
页数：2
相关论文
共 50 条
  • [1] The therapeutic landscape for cells engineered with chimeric antigen receptors
    Matthew MacKay
    Ebrahim Afshinnekoo
    Jonathan Rub
    Ciaran Hassan
    Mihir Khunte
    Nithyashri Baskaran
    Bryan Owens
    Lauren Liu
    Gail J. Roboz
    Monica L. Guzman
    Ari M. Melnick
    Shixiu Wu
    Christopher E. Mason
    Nature Biotechnology, 2020, 38 : 233 - 244
  • [2] The therapeutic landscape for cells engineered with chimeric antigen receptors
    MacKay, Matthew
    Afshinnekoo, Ebrahim
    Rub, Jonathan
    Hassan, Ciaran
    Khunte, Mihir
    Baskaran, Nithyashri
    Owens, Bryan
    Liu, Lauren
    Roboz, Gail J.
    Guzman, Monica L.
    Melnick, Ari M.
    Wu, Shixiu
    Mason, Christopher E.
    NATURE BIOTECHNOLOGY, 2020, 38 (02) : 233 - +
  • [3] Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors
    Kim, Nayoung
    Lee, Dong-Hee
    Choi, Woo Seon
    Yi, Eunbi
    Kim, HyoJeong
    Kim, Jung Min
    Jin, Hyung-Seung
    Kim, Hun Sik
    BMB REPORTS, 2021, 54 (01) : 44 - 58
  • [4] NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development
    Bashiri Dezfouli, Ali
    Yazdi, Mina
    Pockley, Alan Graham
    Khosravi, Mohammad
    Kobold, Sebastian
    Wagner, Ernst
    Multhoff, Gabriele
    CELLS, 2021, 10 (12)
  • [5] NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer
    Li, Junping
    Hu, Hong
    Lian, Hui
    Yang, Shuo
    Liu, Manting
    He, Jinping
    Cao, Bihui
    Chen, Dongni
    Hu, Yuling
    Zhi, Chen
    Shen, Yan
    Ye, Xiaodie
    He, Bingjia
    Zhao, Ming
    Fan, Weijun
    Xu, Linfeng
    Leidner, Rom
    Wu, Qingde
    Yang, Lili
    Zhang, Zhenfeng
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (05): : 1578 - 1601
  • [6] Efficient killing of target cells in vitro by transiently engineered chimeric antigen receptor expressing NK cells
    Meyer, J.
    Meyer, J.
    Morgan, M.
    Falk, C. S.
    Abken, H.
    Schambach, A.
    Galla, M.
    HUMAN GENE THERAPY, 2017, 28 (12) : A26 - A26
  • [7] Signaling Domain of Chimeric Antigen Receptors Can Reprogram T Cells
    Kawalekar, Omkar Uday
    O'Connor, Roddy
    Guedan, Sonia
    Fraietta, Joseph
    Posey, Avery D.
    Scholler, John
    Milone, Michael C.
    June, Carl H.
    BLOOD, 2014, 124 (21)
  • [8] Engineering NK cells to express nanobody-based Chimeric Antigen Receptors (CARs)
    Hambach, J.
    Riecken, K.
    Albrecht, B.
    Cichutek, S.
    Jung, M.
    Fehse, B.
    Bannas, P.
    Koch-Nolte, F.
    HUMAN GENE THERAPY, 2019, 30 (11) : A68 - A68
  • [9] Adapter Chimeric Antigen Receptor (ADCAR)-Engineered NK-92 Cells Targeting Neuroblastoma
    Buchner, M.
    Grote, S.
    Jung, G.
    Baden, C.
    Mittelstaet, J.
    Kaiser, A.
    Handgretinger, R.
    Schleicher, S.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S425 - S426
  • [10] CHIMERIC ANTIGEN RECEPTOR-ENGINEERED T CELLS: WHERE ARE WE NOW AND WHERE ARE WE HEADED?
    Gill, Saar
    LEUKEMIA RESEARCH, 2015, 39 : SS1 - SS2
12345